Alunbrig 90 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FG1UJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,255
Award facts
- Contract value 100% obligated
- $13,255.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,255.37 to AmerisourceBergen Drug Corp for the supply of Alunbrig 90 mg tablets (30-count units) with an ultimate completion date of December 24, 2025. This firm fixed-price, competitively awarded delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military and veteran healthcare systems.
This delivery order is issued without set-aside designation under open competition, consistent with AmerisourceBergen's broader federal contracting pattern. The DLA Troop Support Medical contract vehicle under which this award is issued enables comprehensive pharmaceutical support for military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. Alunbrig (alectinib), a targeted cancer therapy, represents the type of specialty medication included within the prime vendor's extensive pharmaceutical portfolio. AmerisourceBergen's significant federal contract awards and capacity to fulfill orders across diverse price points and therapeutic categories demonstrate the company's substantial role in supporting federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FG1UJ?
SPE2DR26FG1UJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FG1UJ worth?
The government has obligated $13,255 on SPE2DR26FG1UJ.
Is contract SPE2DR26FG1UJ an order under another contract?
Yes. SPE2DR26FG1UJ is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG1UJ competed?
The extent of competition for SPE2DR26FG1UJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award